Home The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results
Article
Licensed
Unlicensed Requires Authentication

The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results

  • Kiyoshi Ichihara EMAIL logo , Ferruccio Ceriotti , Mori Kazuo , Yang-Yang Huang , Yoshihisa Shimizu , Haruki Suzuki , Masami Kitagawa , Kazuyoshi Yamauchi , Sadao Hayashi , Chia-Chun Tsou , Yoshikazu Yamamoto , Shigeo Ishida , Linda Leong , Michitaka Sano , Hwan Sub Lim , Akira Suwabe , Hee-Yeon Woo , Keiya Kojima and Yoshio Okubo
Published/Copyright: February 23, 2013

Abstract

Background: The 2009 Asian multicenter study for derivation of reference intervals (RIs) featured: 1) centralized measurements to exclude reagent-dependent variations; 2) inclusion of non-standardized analytes (hormones, tumor makers, etc.) in the target; and 3) cross-check of test results between the central and local laboratories. Transferability of centrally derived RIs for non-standardized analytes based on the cross-check was examined.

Methods: Forty non-standardized analytes were centrally measured in sera from 3541 reference individuals recruited by 63 laboratories. Forty-four laboratories collaborated in the cross-check study by locally measuring aliquots of sera from 9 to 73 volunteers (average 22.2). Linear relationships were obtained by the major-axis regression. Error in converting RIs using the regression line was expressed by the coefficient of variation of slope b [CV(b)]. CV(b) <10% was set as the cut-off value allowing the conversion. The significance of factors for partitioning RIs was determined similarly as in the first report.

Results: Significant sex-, age-, and region-related changes in test results were observed in 17, 15, and 11 of the 40 analytes, respectively. In the cross-comparison study, test results were not harmonized in the majority of immunologically measured analytes, but their average CV(b)s were <10% except for total protein, cystatin C, CA19-9, free thyroxine, and triiodothyronine. After conversion, 74% of centrally derived RIs were transferred to each local laboratory.

Conclusions: Our results point to the feasibility of: 1) harmonizing test results across different laboratories; and 2) sharing centrally derived RIs of non-standardized analytes by means of comparative measurement of a set of commutable specimens.


Corresponding author: Kiyoshi Ichihara, MD, PhD, Faculty of Health Sciences, Department of Clinical Laboratory Sciences, Yamaguchi University Graduate School of Medicine, Minami-Kogushi 1-1-1, Ube 755-8505, Japan, Phone: +81 836 222884, Fax: +81 836 355213

This research was planned collaboratively by the: 1) Committee on Plasma Proteins (C-PP) and Committee on Reference Intervals and Decision Limits (C-RIDL) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC); 2) the Scientific Committee of the Asia-Pacific Federation for Clinical Biochemistry (APFCB); 3) the Working Group on the Guideline for Common Reference Interval in the Japan Society of Laboratory Medicine (JSLM), and 4) the Committee on Plasma Protein of the Japan Society of Clinical Chemistry (JSCC). This study was also supported by the C-RIDL of the IFCC.

Research funds used included a Scientific Research Fund (No. 21406015: 2009–2011) provided by Japan Society for the Promotion of Science; a Research Promotion Project Fund of the JSLM (2008–2009); and a Scientific Research Fund of the APFCB.

The clinical laboratories taking part in this cross-comparison study belong to the following institutions:

Outside Japan: 1) Gangnam Severance Hospital, Yonsei University, Seoul; 2) Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul; 3) Myongji Hospital, Kwandong University College of Medicine, Gyeonggi-do; 4) Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong; 5) Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau; 6) Mackay Memorial Hospital, Taipei; 7) Cathay General Hospital, Taipei; 8) Yuan Ching Clinical Laboratory, Taipei; 9) National Cheng Kung University, Tainan; 10) Chi-Mei Medical Center, Tainan; 11) National Heart Institute, Kuala Lumpur; 12) Gleneagles Intan Medical Centre, Kuala Lumpur; and 13) Medic-Lab, Ho Chi Minh City.

Inside Japan: 14) Keiyu Corp. Yoshida Hospital, Asahikawa; 15) Hokkaido University, Sapporo; 16) Kishimoto Clinical Laboratory, Tomakomai; 17) Iwate Medical School, Morioka; 18) Hirosaki University, Hirosaki; 19) Hachinohe Red-Cross Hospital, Hachinohe; 20) Hachinohe City Hospital, Hachinohe; 21) Chiba Cardiovascular Center, Ichihara; 22) Chiba University, Chiba; 23) Funabashi Municipal Medical Center, Funabashi; 24) Tokyo Medical and Dental University Chiba Hospital, Chiba; 25) Tokyo University, Tokyo; 26) Shinshu University, Matsumoto; 27) Yamanashi University, Kofu; 28) Nagoya University, Nagoya; 29) Anjo Kosei Hospital, Anjo; 30) Fujita Health University, Toyoake; 31) Osaka University, Suita; 32) Tenri Hospital, Tenri; 33) Osaka Municipal University, Osaka; 34) National Cardiovascular Center, Suita; 35) Kawasaki Medical School, Kurashiki; 36) Kurashiki Central Hospital, Kurashiki; 37) Okayama University, Okayama; 38) Okayama Medical Laboratory, Kurashiki; 39) Yamaguchi University, Ube; 40) Tokuyama Central Hospital, Shunan; 41) Yamaguchi Prefectural Medical Center, Hofu; 42) Saiseikai Yamaguchi Hospital, Yamaguchi; 43) Kochi Medical School, Nangoku; and 44) Ryukyu University Hospital, Naha.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Appendix 1

Estimation of standard error of slope b by the reduced major axis regression

Assuming a dataset consisting of n points of data pair (x and y), the reduced major axis regression is expressed as follows:

where , represents the means of x and y. The slope b is derived as follows:

The mathematical method to derive standard error (SE) of b, SE(b), is not known and commonly approximated by SE of slope b’, SE(b’), by the ordinary least-square method by the following formula (references 2, 4).

where s represents the standard deviation of data points around the ordinary least-square regression line. s is derived as follows with Y representing a predicted y for a given x, or , and r representing the correlation coefficient.

Using the last formula, approximated SE(b) can be expressed as follows.

Therefore, CV of slope b, or CV(b), can be expressed as follows:

References

1. Ichihara K, Ceriotti F, Tam TT, Sueyoshi S, Poon PM, Thonget ML, et al. The Asian project for collaborative derivation of reference intervals: (1) strategy and major resultsof standardized analytes. Clin Chem Lab Med 2013;51:1429–42.10.1515/cclm-2012-0421Search in Google Scholar PubMed

2. Sokal RR, Rohlf FJ. Linear regression (Model II regression). In Biometry: the principles and practice of statistics in biological research, 3rd ed. San Francisco: W. H. Freeman, 1995:541–9.Search in Google Scholar

3. McArdle BH. The structural relationship: regression in biology. Can J Zool 1988;66:2329–39.10.1139/z88-348Search in Google Scholar

4. Draper NR, Smith H. Applied regression analysis, 3rd ed. New York: John Wiley & Sons, 1998.10.1002/9781118625590Search in Google Scholar

5. Davison AC, Hinkley DV. Bootstrap methods and their application. Cambridge: Cambridge University Press, 1997.10.1017/CBO9780511802843Search in Google Scholar

6. NCCLS. Method comparison and bias estimation using patient samples; approved guideline, 2nd ed. NCCLS document EP9-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2002.Search in Google Scholar

7. Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem 1999;45:882–94.10.1093/clinchem/45.6.882Search in Google Scholar

8. Miller GW, Myers GL, Gantzer ML, Kahn SE, Schönbrunner RE, Thienpont LM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011;57:1108–17.10.1373/clinchem.2011.164012Search in Google Scholar PubMed

9. Ozarda Y, Sucu DK, Hizli B, Aslan D. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochem Funct 2009;27:568–77.10.1002/cbf.1610Search in Google Scholar PubMed

Received: 2012-6-29
Accepted: 2013-1-8
Published Online: 2013-02-23
Published in Print: 2013-07-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorials
  4. Biomarkers in the treatment of cancer: opportunities and pitfalls
  5. Multicenter reference intervals studies: a promising perspective for the future?
  6. Hemolysis-resistant reagent: another part of the puzzle for preventing errors in laboratory testing
  7. Review
  8. Exhaled breath condensate: a comprehensive update
  9. Mini Review
  10. Psoriasis, a new challenge for laboratory medicine
  11. Opinion Paper
  12. CA 19-9: handle with care
  13. General Clinical Chemistry and Laboratory Medicine
  14. Performance evaluation of human cytokines profiles obtained by various multiplexed-based technologies underlines a need for standardization
  15. The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study
  16. Red blood cell distribution width is a potential prognostic index for liver disease
  17. Development of a novel, hemolysis-resistant reagent for assessment of α-amylase in biological fluids
  18. Performance of cassette-based blood gas analyzers to monitor blood glucose and lactate levels in a surgical intensive care setting
  19. Reference Values and Biological Variations
  20. The Asian project for collaborative derivation of reference intervals: (1) strategy and major results of standardized analytes
  21. The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results
  22. Cancer Diagnostics
  23. Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China
  24. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids
  25. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules
  26. Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer
  27. Elevated tumor markers in patients with pulmonary alveolar proteinosis
  28. Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers
  29. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
  30. Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
  31. Cardiovascular Diseases
  32. Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy
  33. Diabetes
  34. α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients
  35. Infectious Diseases
  36. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study
  37. Letters to the Editor
  38. Carryover does not affect results of Beckman Coulter highly-sensitive-AccuTnI assay on Access 2
  39. Adding calcium to EDTA plasma samples prior to analysis could solve the compatibility issue in commercially available ELISAs that are standardized for serum
  40. Interference of luteinizing hormone in the urinary point-of-care human chorionic gonadotropin test
  41. Standardize the serum albumin assay now: calibrate it to 60% of the serum total protein assay
  42. Interference of M-paraprotein in automated urea assays
  43. A case of mistaken diagnosis of heparin-induced thrombocytopenia due to pseudothrombocytopenia
  44. Delta check: a must in the management of hyponatremia
  45. A novel cost effective algorithm for antinuclear antibody (ANA) testing in an outpatient setting
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0422/html
Scroll to top button